LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yan Bi, MD, PhD
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Endocrinology, Changzhou No.2 People'S Hospital, the Affiliated Hospital of Nanjing Medical University
Changzhou, Jiangsu, China
- Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, China
- Department of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
- Department of Endocrinology, the Affiliated Jiangning Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
- Department of Endocrinology, the Affiliated Wuxi People'S Hospital of Nanjing Medical University
Wuxi, Jiangsu, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Oct 2022
- Primary completion
- 31 Dec 2025
- Completion
- 31 Jul 2026
- Last update posted
- 6 Jan 2026
- Registered enrollment
- 396
- Registry id
- NCT05313529
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.